Evidence map›Paper›PMID 41827981›Full record

ArticleDiagnostics (Basel, Switzerland)2026

A Novel Approach Using Microarray Testing as a Screening Method with Clinical Validation Using Whole-Genome Sequencing and Karyotyping for Identifying 46,XX Testicular Differences of Sex Development.

Takeshi Ozeki, Yuka Nakano, Ayumu Ishigaki, Yoichi Kawashima, Charles W Crawford, David D Ordinario, Iri Sato-Baran, Toshihiko Higashida

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Takeshi OzekiGenesis Institute of Genetic Research, Genesis Healthcare Co., Yebisu Garden Place Tower 26F, 4-20-3 Ebisu, Shibuya-ku, Tokyo 150-6026, Japan.ORCID 0000-0001-6221-2189
Yuka NakanoGenesis Institute of Genetic Research, Genesis Healthcare Co., Yebisu Garden Place Tower 26F, 4-20-3 Ebisu, Shibuya-ku, Tokyo 150-6026, Japan.
Ayumu IshigakiGenesis Institute of Genetic Research, Genesis Healthcare Co., Yebisu Garden Place Tower 26F, 4-20-3 Ebisu, Shibuya-ku, Tokyo 150-6026, Japan.
Yoichi KawashimaGenesis Institute of Genetic Research, Genesis Healthcare Co., Yebisu Garden Place Tower 26F, 4-20-3 Ebisu, Shibuya-ku, Tokyo 150-6026, Japan.
Charles W CrawfordGenesis Institute of Genetic Research, Genesis Healthcare Co., Yebisu Garden Place Tower 26F, 4-20-3 Ebisu, Shibuya-ku, Tokyo 150-6026, Japan.ORCID 0009-0001-7214-8974
David D OrdinarioGenesis Institute of Genetic Research, Genesis Healthcare Co., Yebisu Garden Place Tower 26F, 4-20-3 Ebisu, Shibuya-ku, Tokyo 150-6026, Japan.ORCID 0009-0007-5625-1588
Iri Sato-BaranGenesis Institute of Genetic Research, Genesis Healthcare Co., Yebisu Garden Place Tower 26F, 4-20-3 Ebisu, Shibuya-ku, Tokyo 150-6026, Japan.
Toshihiko HigashidaSouseikai Medical Group, Medical Clinic Ebisu, Yebisu Garden Place Tower 26F, 4-20-3 Ebisu, Shibuya-ku, Tokyo 150-6026, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

46,X,der(X)t(Xchromosomal translocationdirect-to-consumer genetic testing servicep11.1)SRYXX maleY)(p22.3

Identifiers

PMID41827981
PMCPMC12984122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.